Natural gas prices have retreated as traders take profits near multi-week highs and respond to warmer weather forecasts, with key support levels at $3.00-$3.05 and resistance at $3.25-$3.45. Meanwhile, WTI oil prices are rising due to ongoing tensions in Saudi Arabia and attacks on energy assets by Iran-backed Houthis, with WTI aiming to break above $95.00 and potentially test $100.50-$101.00. Brent oil remains volatile near $106, needing positive catalysts to push higher towards $109.50 and beyond. These developments highlight continued geopolitical risks and supply uncertainties affecting energy markets.
Natural gas and oil price movements provide context for energy market conditions. For readers following these commodities, here is Pluang's market snapshot as of Oct 15, 2026 00:22 WIB: out of 150 priced US stocks tradable on Pluang, 39 rose and 111 fell today. Notable movers include Hewlett Packard Enterprise Co (HPE) with a price of USD 63.33 and a 1-day change of -7.95%, JetBlue Airways Corporation (JBLU) at USD 3.08 down 7.91%, and Robinhood Markets, Inc. (HOOD) at USD 101.80 down 7.89%.
Jefferies has maintained a Buy rating on Big Yellow Group despite recent stock declines, citing the company's strong fundamentals including freehold properties and solid cash flows. Activist investor Ancora, holding over 4% of shares, is pushing Big ...
Fastenal reported strong Q3 2026 earnings, beating analyst expectations with EPS of $0.35 and revenue of $2.46 billion. The company saw a 20% rise in net income to $401.6 million and a 15.5% increase in revenue driven by robust manufacturing demand, ...
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform ...
